Behavioral: pelvic floor muscle exercise-based behavioral therapy (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03149809 (ClinicalTrials.gov) | March 1, 2018 | 9/5/2017 | Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease | Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease | Overactive Bladder;Parkinson Disease | Drug: solifenacin;Behavioral: Pelvic floor muscle exercise-based behavioral therapy | VA Office of Research and Development | NULL | Recruiting | N/A | N/A | All | 90 | Phase 3 | United States |